ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

Xu, Feng; He, Lulu; Zhan, Xueqin; Chen, Jiexin; Xu, Huan; Huang, Xiaoling; Li, Yangyi; Zheng, Xiaohe; Lin, Ling*; Chen, Yongsong*汕头大学; 浙江大学; 1
Aging-US2020-12-31
3被引10阅读
引用收藏
分享

摘要

The marked heterogeneity of lung adenocarcinoma (LUAD) makes its diagnosis and treatment difficult. In addition, the aberrant DNA methylation profile contributes to tumor heterogeneity and alters the immune response. We used DNA methylation array data from publicly available databases to establish a predictive model for LUAD prognosis. Thirty-three methylation sites were identified as specific prognostic biomarkers,independent of patients' clinical characteristics. These methylation profiles were used to identify potential drug candidates and study the immune microenvironment of LUAD and response to immunotherapy. When compared with the high-risk group, the low-risk group had a lower recurrence rate and favorable prognosis. The tumor microenvironment differed between the two groups as reflected by the higher number of resting dendritic cells and a lower number of monocytes and resting mast cells in the low-risk group. Moreover, low-risk patients reported higher immune and stromal scores, lower tumor purity, and higher expression of HLA genes. Low-risk patients responded well to immunotherapy due to higher expression of immune checkpoint molecules and lower stemness index. Thus, our model predicted a favorable prognosis and increased overall survival for patients in the low-risk methylation group. Further, this model could provide potential drug targets to develop effective immunotherapies for LUAD.

学科与关键词

关键词
DNA methylationlung adenocarcinomaprognosisrecurrenceimmunotherapy
相关
加载中…
  • Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes
    Yu, Ruilin; Huang, Xiaoming; Lin, Junqi; Lin, Shaoming; Shen, Guanle; Chen, Wenbiao*Journal of Thoracic Disease, 2023, 15(4): 2184-+.
  • Characterization of lung adenocarcinoma based on immunophenotyping and constructing an immune scoring model to predict prognosis
    Liu, Mengfeng; Xiao, Qifan; Yu, Xiran; Zhao, Yujie; Qu, Changfa*Frontiers in Pharmacology, 2022, 13: 1081244.
  • Mining the Prognostic Role of DNA Methylation Heterogeneity in Lung Adenocarcinoma
    Liao, Hongying; Luo, Xiaolong; Huang, Yisheng; Yang, Xingping; Zheng, Yuzhen; Qin, Xianyu; Tan, Jian; Shen, Piao; Tian, Renjiang; Cai, Weijie; Shi, Xiaoshun*; Deng, Xiaofang*DISEASE MARKERS, 2022, 2022: 9389372.
查看全部 →

发表信息

论文状态
公开发表
期刊
Aging-US
发表日期
2020-12-31
卷期
第 12 卷, 第 24 期
页码
25275-25293
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672640]; Grant for Key Disciplinary Project of Clinical Medicine under the Guangdong High-Level University Development Program [002-18120310]; Special Funds for Innovation Strategy of Science and Education in Guangdong Province [2018-157]; Special Funds for Science and Technology of Guangdong Province [2019-113]; Science and Technology Planning Project of Shantou City [2019-106]; Guangdong Basic and Applied Basic Research Foundation [2020A1515011519]; Medical Science and Technology Research Foundation of Guangdong Province [A2020430]; "Dengfeng Project" for the construction of high-level hospitals in Guangdong Province-the First Affiliated Hospital of Shantou University Medical College Supporting Funding [2019-70]

作者

  • X

    Xu, Feng (第一作者)

    1 · shantou univ

  • H

    He, Lulu

    1 · zhejiang univ

查看全部 10 位作者收起作者
  • Z

    Zhan, Xueqin

    zhejiang univ

  • C

    Chen, Jiexin

    1 · shantou univ

  • X

    Xu, Huan

    1 · shantou univ

  • H

    Huang, Xiaoling

    1 · shantou univ

  • L

    Li, Yangyi

    1 · shantou univ

  • Z

    Zheng, Xiaohe

    1 · shantou univ

  • L

    Lin, Ling (通讯)

    1 · shantou univ

  • C

    Chen, Yongsong (通讯)

    1 · shantou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417